Universal Ibogaine (TSXV:IBO) Change In Payables And Accrued Expense : C$-0.03 Mil (TTM As of Apr. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine Change In Payables And Accrued Expense?

Universal Ibogaine's Change In Payables And Accrued Expense for the quarter that ended in Apr. 2024 was C$-0.01 Mil. It means Universal Ibogaine's Accounts Payable & Accrued Expense declined by C$0.01 Mil from Jan. 2024 to Apr. 2024 .

Universal Ibogaine's Change In Payables And Accrued Expense for the fiscal year that ended in Jul. 2023 was C$0.23 Mil. It means Universal Ibogaine's Accounts Payable & Accrued Expense increased by C$0.23 Mil from Jul. 2022 to Jul. 2023 .

Universal Ibogaine Change In Payables And Accrued Expense Historical Data

The historical data trend for Universal Ibogaine's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Change In Payables And Accrued Expense Chart

Universal Ibogaine Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Jul22

Jul23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

-0.01

0.05

-0.47

0.23

Universal Ibogaine Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-0.09	-0.02	0.09	-0.09	-0.01

Universal Ibogaine Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Apr. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.03 Mil.

Universal Ibogaine Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Ibogaine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

IBOGF:USA JC4:Germany

Address

815 8th Avenue South West, Suite 600, Calgary, AB, CAN, T2P 3P2

Website

https://www.universalibogaine.com

Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.

Executives

Ian Rabb

Senior Officer

Universal Ibogaine Headlines

From GuruFocus

DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value

By Marketwired • 09-16-2024